cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Omega Therapeutics
4 own
3 watching
Current Price
$7.77
$0.01
(0.13%)
logo-omga
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
371.85M
52-Week High
52-Week High
14.31
52-Week Low
52-Week Low
1.975
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization371.85M
icon52-Week High14.31
icon52-Week Low1.975
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio--
What does the Omega Therapeutics do?
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature s operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regeneration; to down-regulate expression of the CXCL1, 2, 3, and IL-8 gene cluster; to control expression of genes implicated in patients with idiopathic pulmonary fibrosis to halt or reverse disease progression and improve disease outcomes; to down-regulate the expression of SFRP1, a protein that inhibits hair growth; and to treat non-small cell lung cancer and small cell lung cancer. It is also developing OTX-2002 to down-regulate c-Myc, an oncogene. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Omega Therapeutics make?
News & Events about Omega Therapeutics.
PR Newswire
3 months ago
Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform PR Newswire CAMBRIDGE, Mass., Oct. 17, 2022 Dr. Khrer has more than 25 years of RNA research and development experience, including pioneering novel...
Zolmax
4 months ago
Omega Therapeutics, Inc. (NASDAQ:OMGA Get Rating) Director Richard A. Young sold 10,000 shares of the companys stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $8.00, for a total value of $80,000.00. Following the completion of the ...
PR Newswire
9 months ago
Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner Flagship Pioneering Expands Leadership Team with Appointment of Michael Severino as CEO-Partner PR Newswire CAMBRIDGE, Mass., April 13, 2022 CAMBRIDGE, Mass., April 13, 2022 /PRNewswire/ -- Flagship...
PR Newswire
9 months ago
Omega Therapeutics Presents Preclinical Data on OTX-2002, First-in-Class Epigenomic Controller, as Potential Treatment for Hepatocellular Carcinoma at the AACR Annual Meeting 2022 Omega Therapeutics Presents Preclinical Data on OTX-2002, First-in-Class Epigenomic Controller, as Potential Treatment...
PR Newswire
10 months ago
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022 Ranks #2 Most Innovative Company in North America PR Newswire CAMBRIDGE, Mass., March...
Frequently Asked Questions
Frequently Asked Questions
What is Omega Therapeutics share price today?
plus_minus_icon
Can Indians buy Omega Therapeutics shares?
plus_minus_icon
How can I buy Omega Therapeutics shares from India?
plus_minus_icon
Can Fractional shares of Omega Therapeutics be purchased?
plus_minus_icon
What are the documents required to start investing in Omega Therapeutics stocks?
plus_minus_icon
What is today’s traded volume of Omega Therapeutics?
plus_minus_icon
What is today’s market capitalisation of Omega Therapeutics?
plus_minus_icon
What is the 52-Week High and Low Range of Omega Therapeutics?
plus_minus_icon
What percentage is Omega Therapeutics down from its 52-Week High?
plus_minus_icon
What percentage is Omega Therapeutics up from its 52-Week Low?
plus_minus_icon
Current Price
$7.77
$0.01
(0.13%)
logo-omga
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00